Stories from The University of Texas Health Science Center at Houston (UTHealth Houston)
November 1, 2023
Wanida Ono, DDS, PhD, associate professor with UTHealth Houston School of Dentistry has received a $2.5 million federal grant from the National Institute of Dental and Craniofacial Research of the National Institutes of Health to study tooth eruption disorders and potential therapies.
October 31, 2023
A five-year, $6.2 million grant to implement a hospital-based intervention program to address firearm violence has been awarded to researchers at UTHealth Houston by the National Institute of Nursing Research, part of the National Institutes of Health.
October 26, 2023
A four-year, $3.4 million grant to investigate molecular mechanisms and therapeutic treatments for acute respiratory distress syndrome (ARDS) has been awarded to UTHealth Houston researchers by the National Heart, Lung, and Blood Institute, part of the National Institutes of Health.
October 24, 2023
Two different regions of the brain are critical to integrating semantic information while reading, which could shed more light on why people with aphasia have difficulty with semantics, according to new research from UTHealth Houston.
October 23, 2023
Zhiqiang An, PhD, has been named UTHealth Houston’s first vice president of drug discovery. In this new role, An will work in close collaboration with researchers across campus, as well as the Office of Technology Management, Academic and Faculty Affairs, and the Office of the President to promote drug discovery and therapeutic innovation.
October 20, 2023
Just as a song can remind us of the junior high dance or prom, sounds also have the ability to return traumatic memories.
Pinpointing the location of these traumatic memories is the work behind a clinical trial, “Neuromodulation of the fear extinction circuit using temporally and anatomically specific TMS in humans,” led by Mohammed Milad, PhD, professor in the Louis A. Faillace Department of Psychiatry and Behavioral Sciences at McGovern Medical School at UTHealth Houston.
October 19, 2023
The Texas Therapeutics Institute at UTHealth Houston, led by Zhiqiang An, PhD, is expanding into the Texas Medical Center’s newly completed TMC3 Collaborative Building.
The institute, part of The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases with McGovern Medical School at UTHealth Houston, focuses on antibody drug resistance mechanisms, biomarkers for therapeutic antibodies, and antibody drug discovery targeting human diseases.
October 18, 2023
A five-year, $6.4 million grant to develop an integrated, multiscale artificial intelligence (AI) approach to study genetic factors associated with Alzheimer’s disease has been awarded to UTHealth Houston by the National Institute on Aging, part of the National Institutes of Health.
October 11, 2023
Demetrios Stroubakis, 55, thought he was having a gallbladder attack when he arrived at the emergency room in August 2021 with jaundice. Instead, he was shocked to be diagnosed with pancreatic cancer.
October 6, 2023
The offspring of adolescent and young adult women with a history of cancer face a higher risk of birth defects, according to new research from UTHealth Houston.
Use the form below to perform a new search.